Aptevo Therapeutics Stock Quote APVO - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.4118

Bid

0.425

Ask

0.424

Volume

2,664,764

0.3816 Day's Range 0.45

0.2848 52 Week Range 50.16

Market Cap

1.796M

Previous Close

0.4401

Open

0.405

Last Trade

0.405

Last Trade Time

18:22:25

Financial Volume

$ 1,092,217

VWAP

0.409874

Average Volume (3m)

7,050,242

Shares Outstanding

4,080,169

Dividend Yield

PE Ratio

-0.10

Earnings Per Share (EPS)

-4.27

Revenue

Net Profit

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptevotherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $0.44. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.2848 to $ 50.16.

Aptevo Therapeutics currently has 4,080,169 shares outstanding. The market capitalization of Aptevo Therapeutics is $1.80 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.10.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1169	39.6405561207	0.2949	0.6559	0.285	68408043	0.57079694	CS
4	-0.1274	-23.6275964392	0.5392	0.6559	0.2848	19605384	0.56322087	CS
12	-0.3482	-45.8157894737	0.76	1.38	0.2848	7050242	0.61405346	CS
26	-6.9054	-94.3721642158	7.3172	10.8	0.2848	3440026	0.91139487	CS
52	-48.4282	-99.1568386568	48.84	50.16	0.2848	1931091	2.38311306	CS
156	-922.2682	-99.9553691421	922.68	971.5156	0.2848	1049838	211.65755322	CS
260	-38.3698	-98.938156239	38.7816	2640	0.2848	844173	281.76422218	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LIFWMSP Recovery Inc	$ 0.702 (38.54%)	14.17M
HOVRNew Horizon Aircraft Ltd	$ 0.693 (28.81%)	307.08k
FEIMFrequency Electronics Inc	$ 13.00 (28.71%)	138.78k
TUSKMammoth Energy Services Inc	$ 4.50 (28.57%)	215.16k
LGHLWLion Group Holding Ltd	$ 0.0088 (23.94%)	300
RNAZTransCode Therapeutics Inc	$ 0.48 (-39.43%)	293.72k
NUKKNukkleus Inc	$ 0.4101 (-17.65%)	790.73k
CMAXCareMax Inc	$ 4.32 (-16.76%)	1M
MEDPMedpace Holdings Inc	$ 367.0624 (-16.04%)	14.29k
MIRAMIRA Pharmaceuticals Inc	$ 4.21 (-15.97%)	10.13M
NVDANVIDIA Corporation	$ 123.61 (0.06%)	23.8M
LIFWMSP Recovery Inc	$ 0.7086 (39.85%)	14.17M
MIRAMIRA Pharmaceuticals Inc	$ 4.20 (-16.17%)	10.13M
SLNASelina Hospitality PLC	$ 0.039 (5.41%)	3.23M
LUXHLuxUrban Hotels Inc	$ 0.1635 (11.00%)	3.05M